Benefits of metabolic surgery on macrovascular outcomes in adult patients with type 2 diabetes: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Benefits of metabolic surgery on macrovascular outcomes in adult patients with type 2 diabetes: a systematic review and meta-analysis

Published:2024-02 Issue:2 Volume:20 Page:202-212
ISSN:1550-7289
Container-title:Surgery for Obesity and Related Diseases
language:en
Short-container-title:Surgery for Obesity and Related Diseases

Author:

Obeso-Fernández Javier,Millan-Alanis Juan Manuel,Sáenz-Flores Melissa,Rodríguez-Bautista Mario,Medrano-Juarez Samantha^ORCID,Oyervides-Fuentes Stephie^ORCID,Gonzalez-Cruz Daniela,Manzanares-Gallegos Dulce Maria^ORCID,González-González José Gerardo,Rodríguez-Gutiérrez René

Publisher

Elsevier BV

Subject

Surgery

Reference34 articles.

1. World Health Organization (WHO) [Internet]. Geneva, Switzerland: WHO; [updated 2021 Jun 9; cited 2022 Nov 12]. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

2. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045;Sun;Diabetes Res Clin Pract,2022

3. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017;Einarson;Cardiovasc Diabetol,2018

4. Effects of intensive glucose lowering in type 2 diabetes;N Engl J Med,2008

5. Glucose control and vascular complications in veterans with type 2 diabetes;Duckworth;N Engl J Med,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers;Expert Review of Clinical Pharmacology;2023-09-28